Schroeter, Christina B.
Rolfes, Leoni
Gothan, K. S. Sophie
Gruchot, Joel
Herrmann, Alexander M.
Bock, Stefanie
Fazio, Luca
Henes, Antonia
Narayanan, Venu
Pfeuffer, Steffen
Nelke, Christopher
Räuber, Saskia
Huntemann, Niklas
Duarte-Silva, Eduardo
Dobelmann, Vera
Hundehege, Petra
Wiendl, Heinz
Raba, Katharina
Küry, Patrick
Kremer, David
Ruck, Tobias
Müntefering, Thomas
Budde, Thomas
Cerina, Manuela
Meuth, Sven G.
Funding for this research was provided by:
EMD Serono
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
Article History
Received: 2 September 2021
Accepted: 7 September 2022
First Online: 8 November 2022
Declarations
:
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed (Landesamt für Natur, Umwelt und Verbraucherschutz, North Rhine-Westphalia, Germany (84-02.04.2015.A585)). All patients included in this study gave their written informed consent in accordance with the Declaration of Helsinki and a protocol approved by the Ethics Committee of the University of Duesseldorf (5951R).
: All authors qualify for authorship according to current guidelines of <i>Journal of Neuroinflammation</i>. All authors have read and agreed to the submitted version of the manuscript. The current manuscript is not submitted to or under revision at another journal. The submitting author hereby declares that she takes responsibility for conduction and analysis of the data and that he had full access to all study data. The submitting author furthermore declares that there are no competing interests concerning these data and that the authors have all rights to publish the data. The submitted manuscript does not contain data that have been published in any other journal. The authors have no related articles under submission.
: Christina B. Schroeter: None. Leoni Rolfes: received travel reimbursements from Merck Serono and Sanofi Genzyme, research support from Diamed, Merck Serono and Novartis. Her research is funded by the Interdisciplinary Center for Clinical Studies (IZKF) Muenster. K. S. Sophie Gothan: None. Joel Gruchot: None. Alexander M. Herrmann: None. Stefanie Bock: None. Luca Fazio: None. Antonia Henes: None. Venu Narayanan: None. Steffen Pfeuffer: received travel grants from Sanofi Genzyme and Merck Serono, lecturing honoraria from Sanofi Genzyme, Mylan Healthcare, and Biogen, and research support from Diamed, Merck Serono, and the German Multiple Sclerosis Society Northrhine-Westphalia. Christopher Nelke: None. Saskia Räuber: None. Niklas Huntemann: None. Eduardo Duarte-Silva: None. Vera Dobelmann: None. Petra Hundehege: None. Heinz Wiendl: None. Katharina Raba: None. Patrick Küry: None. David Kremer: None. Tobias Ruck: received travel expenses and financial research support from Genzyme and Novartis and received honoraria for lecturing from Roche, Merck, Genzyme, Biogen, and Teva. Thomas Müntefering: None. Thomas Budde: received research funding from Biogen, DFG and IZKF Münster. Manuela Cerina: None. Sven G. Meuth: received honoraria for lecturing and travel expenses for attending meetings from Almirall, Amicus Therapeutics Germany, Bayer Health Care, Biogen, Celgene, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, Roche, Sanofi-Aventis, Chugai Pharma, QuintilesIMS, and Teva. His research is funded by the German Ministry for Education and Research (BMBF), Deutsche Forschungsgemeinschaft (DFG), Else Kröner Fresenius Foundation, German Academic Exchange Service, Hertie Foundation, Interdisciplinary Center for Clinical Studies (IZKF) Muenster, German Foundation Neurology, and by Almirall, Amicus Therapeutics Germany, Biogen, Diamed, Fresenius Medical Care, Genzyme, Merck Serono, Novartis, ONO Pharma, Roche, and Teva.